| Bioactivity | Metixene (Piperidine) hydrochloride hydrate is an anticholinergic and antiparkinsonian agent. Metixene hydrochloride potently inhibits binding of quinuclidinyl benzilate (QNB) with the muscarinic receptor, IC50 and Ki values of 55 nM and 15 nM, respectively. Metixene hydrochloride can be used for the research of parkinsonian[1][2][3]. |
| Invitro | Metixene hydrochloride can potentially inhibit the binding of QNB with the muscarinic receptor， IC50 and Ki values of 55 nM and 15 nM, respectively[3]. |
| Name | Metixene hydrochloride |
| CAS | 1553-34-0 |
| Formula | C20H24ClNS |
| Molar Mass | 345.93 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Syvälahti EK, et al. Effects of antiparkinsonian drugs on muscarinic receptor binding in rat brain, heart and lung. Pharmacol Toxicol. 1988 Feb;62(2):90-4. [2]. J. Hagenah, et al. Exogenous levodopa is not toxic to elderly subjects with non-parkinsonian movement disorders: further clinical evidence. , 106(3-4), 301–307. doi:10.1007/s007020050159 [3]. S L Levin, et al. Dualism in the effect of cholinolytics upon the human parotid gland deprived of parasympathetic control. Int J Clin Pharmacol Res. 1986;6(5):429-39. |
Metixene hydrochloride
CAS: 1553-34-0 F: C20H24ClNS W: 345.93
Metixene (Piperidine) hydrochloride hydrate is an anticholinergic and antiparkinsonian agent. Metixene hydrochloride pot
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.